<DOC>
	<DOCNO>NCT00266526</DOCNO>
	<brief_summary>Specific immunotherapy recombinant birch pollen allergen rBet v1-FV</brief_summary>
	<brief_title>Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Positive RAST result birch pollen Positive Skin Prick Test reaction birch pollen positive nasal provocation test result birch pollen extract serious chronic disease relevant seasonal allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Birch pollen</keyword>
	<keyword>Recombinant</keyword>
</DOC>